Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy
Journal of Cancer Research & Clinical Oncology, 06/03/09
Tomita N et al. - In a study to assess the effectiveness of early salvage radiotherapy (RT) for pts with prostate-specific antigen (PSA) relapse after radical prostatectomy (RP) retrospectively, it was shown that although a total dose of 60 Gy was effective at low pre-RT PSA levels with short follow-up, an RT dose ≥60 Gy resulted in superior biochemical outcomes even in pts with a pre-RT PSA ≤0.50 ng/ml.
Methods- 51 pts underwent salvage RT for biochemical relapse of prostate cancer (PCa) initially treated with RP.
- All pts had persistent or rising PSA >0.20 ng/ml at some point after surgery, or 3 successive PSA elevations after a postoperative nadir if PSA was ≤0.20 ng/ml.
- Most (96%) of pre-RT PSA were ≤0.50 ng/ml, and median value was 0.25 ng/ml.
- Median RT dose was 60 Gy.
- Multivariate Cox regression analysis was performed for PSA before RP and salvage RT, margin status, seminal vesicle involvement, extracapsular invasion, Gleason score, PSA doubling time (PSADT), and RT dose to identify significant predictors of biochemical outcome.
- Median follow-up was 36 mos.
- 3-yr biochemical no evidence of disease rate (bNED) was 55.1%.
- On multivariate analysis, only the following factors were significantly associated with improved bNED: PSADT >3.0 mos, Gleason score ≤7, and RT dose ≥60 Gy.
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Today in Surgical Technique...keeping you current
Receive free subspecialty "5-minute updates" via email
Transurethral Vapor Resection of Prostate—An Alternative Treatment for Benign Prostatic Hyperplasia >100 g
Journal of Endourology, 10/23/09
The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons
BJU International, 11/04/09
Are Sexual Problems More Common in Men who have had a Vasectomy? A Population-Based Study of Australian Men
The Journal of Sexual Medicine, 11/04/09
Article Search
Sponsor


See Latest Articles


